Novartis has halted distribution of generic Zantac. Here’s what you need to know.

A version of a popular heartburn medicine is now on hold. There are concerns that the generic version of the drug known as Zantac may cause cancer. Novartis stopped the distribution of its prescription version as a precaution. The move comes after the FDA announced on Friday that it may contain NDMA, a probable carcinogen. Dr. Tara Narula joins “CBS This Morning” to discuss what consumers should know. Source